Dermal injection of cosmetic fillers can lead to irreversible blindness when injected in the forehead, and this possible adverse effect is not typically mentioned to patients.
Vision loss from central retinal artery occlusion occurring, after cosmetic facial enhancement, was irreversible in 3 patients. However, 1 patient had a small amount of recovery with aggressive therapy.
Conclusions and Relevance
Cosmetic facial fillers are not approved for use in the forehead, but off-label use for enhancement in this region is common. To our knowledge, there have been no prior reports of blindness caused by filler injected into the forehead. We present findings of central retinal artery occlusion due to fillers in 3 patients shortly after their cosmetic procedures. The filler presumably enters the central retinal artery via the rich external-internal carotid anastomoses and becomes embedded in the retinal tissues, potentially leading to irreversible and severe vision loss. Physicians performing cosmetic enhancement procedures involving facial fillers need to be aware of this potential complication and should include significant vision loss as a possible rare complication.
A, Color fundus photograph of the left eye demonstrates a partial cherry-red spot in the central macula and scattered intraretinal hemorrhage. B, Fluorescein angiography (FA) of the left eye demonstrates blockage of the inferior branches of the retinal arteries and patchy choroidal nonperfusion. ICG indicates indocyanine green. C, Ocular coherence tomography of the left eye, 1 year later, demonstrates retinal thinning starting just below the fovea. ILM indicates internal limiting membrane; RPE, retinal pigment epithelium.
A, Color fundus photograph of the right eye reveals diffuse retinal whitening and lipid filled arterioles. B, Fluorescein angiography of the right eye in an early frame demonstrates delayed patchy choroidal filling. C, Later frame of the fluorescein angiogram demonstrates incomplete filling of the retinal arteries and patchy choroidal filling.
A, Color fundus photograph of the right eye shows retinal whitening and a cherry-red spot in the central macula. B, Fluorescein angiography of the right eye in an early frame demonstrates patchy choroidal filling and some delayed proximal filling of the arteries on the disc. C, Later frame of the fluorescein angiogram demonstrates incomplete filling of proximal arteries only.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Ophthalmology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.